- Home
- WKHS vs COEP Comparison
WKHS vs COEP Comparison
Compare WKHS & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WKHS | COEP |
|---|---|---|
| Founded | 2007 | 2017 |
| Country | United States | United States |
| Employees | N/A | 7 |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 72.7M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | WKHS | COEP |
|---|---|---|
| Price | $2.77 | $10.68 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $21.00 | N/A |
| AVG Volume (30 Days) | ★ 61.0K | 36.4K |
| Earning Date | 05-14-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $763,173.00 | N/A |
| Revenue This Year | $81.01 | N/A |
| Revenue Next Year | $34.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.53 | $6.32 |
| 52 Week High | $11.80 | $21.41 |
Technical Indicators
Market Signals| Indicator | WKHS | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 26.58 | 38.02 |
| Support Level | $0.92 | $8.95 |
| Resistance Level | $3.60 | $13.23 |
| Average True Range (ATR) | 0.20 | 0.97 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 2.30 | 24.38 |
Price Performance
Historical ComparisonAbout WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.